SEBiotic
Commercial- Indications
- Drug-induced constipation
Company intelligence / Profile preview
Specialty Enzymes & Probiotics' branded products, including ImmunoSEB™ and ProbioSEB CSC3™, showed promising results in clinical trials for post-COVID fatigue and immune support, with features highlighted in the NIH COVID-19 supplement fact sheet. Clinical research supports their efficacy across gut, immune, and systemic health. Multiple human and animal studies published in peer-reviewed journals support claims.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Specialty Enzymes & Probiotics.